A phase II trial of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.

被引：0
|
作者：
Lu, YS
Kuo, SH
Su, WP
Yang, CH
Hsu, C
Yang, TL
Huang, CS
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Mackay Mem Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93S / 93S
页数：1
相关论文
共 50 条
  • [1] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [2] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Yen-Shen Lu
    Dar-Ren Chen
    Ling-Min Tseng
    Dah-Cherng Yeh
    Shou-Tung Chen
    Chia-Ming Hsieh
    Hwei-Chung Wang
    Hsien-Tang Yeh
    Sung-Hsin Kuo
    Chiun-Sheng Huang
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 1257 - 1263
  • [3] A phase II trial of Neoadjuvant docetaxel and capecitabine for locally advanced breast cancer
    Lebowitz, PF
    Eng-Wong, J
    Swain, SM
    Berman, A
    Merino, MJ
    Chow, CK
    Venzon, D
    Zia, F
    Danforth, D
    Liu, E
    Zujewski, J
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6764 - 6769
  • [4] A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer
    Villman, Kenneth
    Ohd, John F.
    Lidbrink, Elisabet
    Malmberg, Lena
    Lindh, Birgitta
    Blomqvist, Carl
    Nordgren, Hans
    Bergh, Jonas
    Bergstrom, Daniel
    Ahlgren, Johan
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1153 - 1160
  • [5] A phase I/II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer.
    Kang, YK
    Kim, TW
    Chang, HM
    Ryu, MH
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 329S - 329S
  • [6] A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
    Jeon, Ye Won
    Kim, Tae Hyun
    Youn, Hyun Jo
    Han, Sehwan
    Jung, Yongsik
    Gwak, Geumhee
    Park, Young Sam
    Kim, Jeong Soo
    Suh, Young Jin
    [J]. JOURNAL OF BREAST CANCER, 2017, 20 (04) : 340 - 346
  • [7] Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cancer.
    Overmoyer, B
    Silverman, P
    Leeming, R
    Shenk, R
    Lyons, J
    Ziats, N
    Jesberger, J
    Dumadag, L
    Remick, S
    Chen, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 58S - 58S
  • [8] Phase II trial of neoadjuvant docetaxel with or without bevacizumab in patients with locally advanced breast cancer.
    Overmoyer, B
    Silverman, P
    Leeming, R
    Shenk, R
    Lyons, J
    Jesberger, J
    Hartman, P
    Dumadag, L
    Chen, H
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S106
  • [9] Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial
    Jakobsen, Anders
    Andersen, Fahimeh
    Fischer, Anders
    Jensen, Lars H.
    Jorgensen, Jens C. R.
    Larsen, Ole
    Lindebjerg, Jan
    Ploen, John
    Rafaelsen, Soren R.
    Vilandt, Jesper
    [J]. ACTA ONCOLOGICA, 2015, 54 (10) : 1747 - 1753
  • [10] Updated results of a randomized phase II trial for neoadjuvant versus adjuvant docetaxel/cisplatin chemotherapy in patients with locally advanced gastric cancer.
    Kim, Young Woo
    Ryu, Keun Won
    Choi, Il Ju
    Kook, Myeong-Cherl
    Park, Young Iee
    Kim, Hark K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345